More

    As growth slows, CFO says Novo Nordisk is prepping for the next generation of weight loss drugs



    [
    Novo Nordisk’s Karsten Munk Knudsen is targeting 800 million obese people globally. Read More
    https://fortune.com/img-assets/wp-content/uploads/2025/02/GettyImages-2186485157-e1738754056223.jpg?resize=1200,600
    https://fortune.com/europe/2025/02/05/cfo-novo-nordisk-prepping-next-generation-weight-loss-drugs/


    Ryan Hogg

    Latest articles

    spot_imgspot_img

    Related articles

    Leave a reply

    Please enter your comment!
    Please enter your name here

    spot_imgspot_img